Integra Lifesciences Holdings Corp (IART)

Surgical & Medical Instruments & Apparatus

Latest Price

$12.75

TTM P/E

79.69

Normalized P/E

TTM Div Yield

Fwd Div Yield

Book Value

13.71

P/B Ratio

0.93

Valuation metrics

Norm. op. income: $112M (median of 7yr)

Tax rate: 16%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$6.02

50% downside

Base FCF: $148M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$2.13

82% downside

95.5% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	10.68M	$191.0M	13.73%	+364.9K	2026-06-30
Rubric Capital Management LP	7.75M	$139.0M	9.97%	--	2026-06-30
Invesco Ltd.	3.75M	$67.0M	4.82%	+263.8K	2026-06-30
Vanguard Portfolio Management LLC	3.74M	$67.0M	4.81%	+56.5K	2026-06-30
Morgan Stanley	3.59M	$64.0M	4.62%	+8.9K	2026-06-30
Paradigm Capital Management Inc	3.44M	$61.0M	4.42%	-573.6K	2026-06-30
Fuller & Thaler Asset Management, Inc.	3.44M	$61.0M	4.42%	-93.4K	2026-06-30
State Street Corp	2.95M	$52.0M	3.79%	+60.3K	2026-06-30
Vanguard Capital Management LLC	2.95M	$52.0M	3.79%	+55.3K	2026-06-30
Neuberger Berman Group LLC	2.36M	$42.0M	3.04%	+249.5K	2026-06-30